NCI-14465
NCI-14465 is an ectonucleotide pyrophosphatase/phosphodiesterase (ENPP1) inhibitor with an IC 50 of 26.4 μM. NCI-14465 can be used in cancer research[1].
Product Specifications
CAS Number
1144534-31-5
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/nci-14465.html
Solubility
10 mM in DMSO
Smiles
NC1=NC(NC2=CC=C3C=CC=CC3=C2)=NC(NC4=CC=C(C)C=C4)=N1.Cl
Molecular Formula
C20H19ClN6
Molecular Weight
378.86
References & Citations
[1]Rohilla A, et al. Structure-based virtual screening and in vitro validation of inhibitors of cyclic dinucleotide phosphodiesterases ENPP1 and CdnP. Microbiol Spectr. 2024 Jan 11;12 (1) :e0201223.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-24319R-PerCP-Cy5.5 100 µL
SIRT2 Polyclonal Antibody, PerCP-Cy5.5 Conjugated
Sign In for Pricing
View Details 
20290-05071 5x 30 µg
Human Heat Shock Protein 90 (HSP90) AssayLite™ Antibody (PerCP Conjugate)
Sign In for Pricing
View Details 
GTR15345646 1 Vial
Lentiviral human ZSCAN4 shRNA (UAS) - Lentiviral human ZSCAN4 shRNA (UAS) plasmid
Sign In for Pricing
View Details 